Gian Camenisch

Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight

Gian Camenisch, Jochem Alsenz, H. Van De Waterbeemd et al. · European Journal of Pharmaceutical Sciences · 1998 · 341 citations

Membrane Formation, Diffusion Resistance, Passive Diffusion +8

Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors

H. Van De Waterbeemd, Gian Camenisch, Gerd Folkers et al. · Quantitative Structure-Activity Relationships · 1996 · 202 citations

Membrane Structure, Engineering, Membrane Characterization +19

Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data

Annett Kunze, Jörg Huwyler, Gian Camenisch et al. · Drug Metabolism and Disposition · 2014 · 110 citations

Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P‐Glycoprotein in the Disposition of Aliskiren

Sujata Vaidyanathan, Gian Camenisch, Helmut Schuetz et al. · The Journal of Clinical Pharmacology · 2008 · 103 citations

Molecular Pharmacology, Metabolic Pathways, Pharmacokinetic Modeling +12

Influence of breast cancer resistance protein (Abcg2) and p‐glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec^®) across the mouse blood–brain barrier

Sébastien Bihorel, Gian Camenisch, Michel Lemaire et al. · Journal of Neurochemistry · 2007 · 98 citations

High-grade Gliomas, Cancer Biology, Glioma +18